|
Volumn 24, Issue 3, 2005, Pages 327-331
|
Clinical analysis of resectable breast cancer: a report of 6 263 cases
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CMF PROTOCOL;
FLUOROURACIL;
METHOTREXATE;
ADJUVANT CHEMOTHERAPY;
ADOLESCENT;
ADULT;
AGE;
AGED;
ARTICLE;
BREAST TUMOR;
CANCER STAGING;
FEMALE;
FOLLOW UP;
HUMAN;
LYMPH NODE METASTASIS;
MALE;
MASTECTOMY;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
PROGNOSIS;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADOLESCENT;
ADULT;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
BREAST NEOPLASMS, MALE;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
LYMPHATIC METASTASIS;
MALE;
MASTECTOMY;
METHOTREXATE;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
|
EID: 33745578350
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (25)
|
References (0)
|